Back to Search
Start Over
SF3B1, RUNX1 and TP53 Mutations Significantly Impact the Outcome of Patients with Lower-Risk Myelodysplastic Syndrome
- Source :
- Blood; November 2022, Vol. 140 Issue: Supplement 1 p6920-6922, 3p
- Publication Year :
- 2022
Details
- Language :
- English
- ISSN :
- 00064971 and 15280020
- Volume :
- 140
- Issue :
- Supplement 1
- Database :
- Supplemental Index
- Journal :
- Blood
- Publication Type :
- Periodical
- Accession number :
- ejs61218532
- Full Text :
- https://doi.org/10.1182/blood-2022-169372